Your browser doesn't support javascript.
loading
Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation.
Elnaggar, Muhammad; Agte, Sarita; Restrepo, Paula; Ram, Meghana; Melnekoff, David; Adamopoulos, Christos; Stevens, Mark M; Kappes, Katerina; Leshchenko, Violetta; Verina, Daniel; Jagannath, Sundar; Poulikakos, Poulikos I; Parekh, Samir; Laganà, Alessandro.
Affiliation
  • Elnaggar M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Agte S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Restrepo P; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ram M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Melnekoff D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Adamopoulos C; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Stevens MM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kappes K; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Leshchenko V; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Verina D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Jagannath S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Poulikakos PI; , Travera, Medford, MA, USA.
  • Parekh S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Laganà A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Hematol Oncol ; 15(1): 109, 2022 08 17.
Article in En | MEDLINE | ID: mdl-35978321

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Receptors, Chimeric Antigen / Multiple Myeloma Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Receptors, Chimeric Antigen / Multiple Myeloma Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: